CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 205 filers reported holding CHEMOCENTRYX INC in Q3 2020. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $121,100,000 | +9116.1% | 3,000 | -91.7% | 1.26% | +326.7% |
Q1 2022 | $1,314,000 | 0.0% | 36,100 | 0.0% | 0.30% | +1.0% |
Q4 2021 | $1,314,000 | -81.6% | 36,100 | -61.7% | 0.29% | -83.0% |
Q3 2021 | $7,131,000 | +76.4% | 94,300 | +62.3% | 1.72% | +61.2% |
Q2 2021 | $4,043,000 | -72.6% | 58,100 | -79.9% | 1.07% | -72.7% |
Q1 2021 | $14,779,000 | -6.4% | 288,600 | +12.9% | 3.91% | -9.3% |
Q4 2020 | $15,783,000 | +1121.6% | 255,600 | +983.1% | 4.31% | +933.8% |
Q3 2020 | $1,292,000 | -87.7% | 23,600 | -87.7% | 0.42% | -88.0% |
Q2 2020 | $10,465,000 | +37.2% | 191,600 | +0.8% | 3.48% | +0.0% |
Q1 2020 | $7,629,000 | – | 190,000 | – | 3.48% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |